PHIZICO Pain Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: PHIZICO Pain Relief
Generic name: MENTHOL
Manufacturer: ER3 BRANDS INC.
Product type: HUMAN OTC DRUG
SPL set ID: 72715dc5-d1e7-4b4b-8e28-4e367abba322
SPL ID: 38612493-1ba6-5b91-e063-6394a90ae78f
Version: 1
Effective date: 2025-06-25
Source export date: 2026-10-12
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/b939c18fdf51df171cf60ce5558819d08ac66bb16bb9991d48cbec91028d783e/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:38:06

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		PHIZICO Pain Relief	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		ER3 BRANDS INC.	openfda.manufacturer_name
ndc	package	85832-621-00	openfda.package_ndc
ndc	product	85832-621	openfda.product_ndc
ndc11	package	85832062100	derived:openfda.package_ndc
rxcui		2475473	openfda.rxcui
spl id		38612493-1ba6-5b91-e063-6394a90ae78f	id
spl set id		72715dc5-d1e7-4b4b-8e28-4e367abba322	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning(s): For external use only. Do not use on damaged or broken skin. Avoid contact with the eyes. Do not bandage tightly. Stop use if rash or irritation develops and lasts. Condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. If pregnant or breast-feeding, ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.